Immediate Impact

5 by Nobel laureates 4 from Science/Nature 50 standout
Sub-graph 1 of 25

Citing Papers

Metabolic dysfunction-associated steatotic liver disease in adults
2025 Standout
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
2024 Standout
1 intermediate paper

Works of Vyjayanthi Krishnan being referenced

Pemvidutide (ALT-801), a novel GLP-1/glucagon dual receptor agonist, achieves rapid and potent reductions in body weight and liver fat: results of a placebo-controlled, double-blind, first-in-human (FIH) clinical trial
2022

Author Peers

Author Last Decade Papers Cites
Vyjayanthi Krishnan 97 126 102 9 237
David Alejandro Bejarano 94 133 115 10 260
Noe B. Mercado 158 154 47 12 268
Sébastien Desfarges 79 162 154 7 286
Niklas Bachmann 125 184 88 5 232
Gaëlle Mercenne 114 167 101 10 269
Slim Fourati 117 81 62 13 271
Naveed Gulzar 55 155 79 14 274
Kévin Tartour 78 122 87 12 247
Aniqa Shahid 163 180 65 18 280
John Bui 105 181 80 9 288

All Works

Loading papers...

Rankless by CCL
2026